|
aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG: Step-by-step restart of IT systems 18-Oct-2024 / 22:14 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. aap Implantate AG (the “Company”) announces with reference to the ad hoc release published on October 15, 2024 at 11:25 p.m. regarding a possible cyberattack that the company’s IT systems are being restarted step by step. Production was resumed after a short interruption and was almost unaffected. The ad hoc announcement on October 15, 2024 was directly preceded by information provided to the Company by the relevant investigating authorities regarding investigations initiated ex officio on suspicion of a cyberattack on the Company. According to the ongoing internal investigation of the incident by IT specialists and the latest information provided to the Company by the investigating authorities, it can be assumed at this point in time that no irregularities, in particular data outflows, have occurred. The Company expects to be able to resume normal operations by the end of next week. Contact: If you have any questions, please contact: aap Implantate AG; R. Di Girolamo; Chairman of the Management Board/CEO; Lorenzweg 5; D-12099 Berlin Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de End of Inside Information 18-Oct-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Understanding metabolic alterations and immune dysfunction in acute-on-chronic liver failure
Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function in patients with pre-existing chronic liver disease.
November 8, 2024